LEXICON PHARMACEUTICALS, INC./DE (LXRX) has 66 open-market insider trades by 22 insiders since 2007. The most active filer is Raymond Debbane, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Pascal Minne | Dir10% Owner | — | 3 | $156.6M | 2018-06-28 |
| Raymond Debbane | Dir | — | 12 | $122.0M | 2026-06-03 |
| Artal Group S.A. | Dir10% Owner | — | 4 | $91.0M | 2026-02-02 |
| International S.c.a. Artal | Dir10% Owner | — | 3 | $81.5M | 2026-02-17 |
| Invus Advisors, L.L.C. | Dir10% Owner | — | 4 | $27.7M | 2017-11-17 |
| Artal International Management S.A. | Dir10% Owner | — | 3 | $16.5M | 2018-06-18 |
| Invus, L.P. | Dir10% Owner | — | 1 | $11.1M | 2017-11-14 |
| Westend S.A. | Dir10% Owner | — | 1 | $6.6M | 2018-06-25 |
| Invus Public Equities Advisors, LLC | Dir10% Owner | — | 1 | $6.0M | 2018-06-12 |
| Invus Global Management, LLC | Dir10% Owner | — | 1 | $2.0M | 2026-02-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Raymond Debbane | Director | Buy | $3K | 2026-02-25 |
| Raymond Debbane | Director | Buy | $147K | 2026-02-23 |
| Raymond Debbane | Director | Buy | $220K | 2026-02-19 |
| Raymond Debbane | Director | Buy | $353K | 2026-02-13 |
| Invus Global Management, LLC | Director & 10% Owner | Buy | $2.0M | 2026-02-02 |
| Lonnel Coats | CEO | Buy | $95K |
Companies that share insiders with LXRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-11-16 |
| Philippe Amouyal | Director | Buy | $202K | 2023-11-13 |
| Lonnel Coats | CEO | Buy | $10K | 2023-11-10 |
| Raymond Debbane | Director | Buy | $2.2M | 2023-10-10 |
| Jeffrey L. Wade | President | Buy | $14K | 2023-09-14 |
| Wendy McDermott | VP & Human Resources | Buy | $11K | 2023-08-04 |
| Lonnel Coats | CEO | Buy | $22K | 2023-06-29 |
| Wendy McDermott | VP & Human Resources | Buy | $24K | 2023-06-23 |
| Lonnel Coats | CEO | Buy | $47K | 2023-06-23 |
| Lonnel Coats | CEO | Buy | $92K | 2023-06-22 |